| Code | Description | Claims | Beneficiaries | Total Paid |
| J0178 |
Injection, aflibercept, 1 mg |
457 |
402 |
$409K |
| J2778 |
Injection, ranibizumab, 0.1 mg |
539 |
494 |
$395K |
| J2777 |
Injection, faricimab-svoa, 0.1 mg |
197 |
189 |
$261K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
2,776 |
2,539 |
$202K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
1,078 |
997 |
$73K |
| 92134 |
|
2,463 |
2,274 |
$63K |
| J9035 |
Injection, bevacizumab, 10 mg |
383 |
360 |
$29K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
287 |
254 |
$17K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
146 |
139 |
$14K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
89 |
84 |
$9K |